Aug 2026· Endocrine· Vol 91· 0 citations· 47 references
Medicine
TL;DR
India had the largest absolute burden of type 2 diabetes in 2023, whereas South Africa had the highest age-standardized DALY and mortality rates and China ranked second in absolute burden but lowest in age-standardized rates.
BACKGROUND
We compared the burden and temporal trends of chronic kidney disease due to type 1 diabetes (T1DM-DKD) and type 2 diabetes (T2DM-DKD) in China, the United States, and the United Kingdom from 1990 to 2023 using Global Burden of Disease (GBD) 2023 data.
METHODS
We extracted incidence, mortality, and disabili...
Zhen-Kun Yang, Xian-Sen Wei, Shi-Min Jiang et al.· Diabetes Research and Clinic...· 0 citations
Aim To examine trends in type 2 diabetes mellitus (T2DM) burden among adults aged ≥ 55 years in Mexico from 1990 to 2021, disaggregated by sex, quinquennial age groups, and subnational level. Materials and Methods We conducted a secondary analysis of Global Burden of Disease (GBD) 2021 data. Age‐specific and age‐standa...
C. Dávila-Cervantes, M. Agudelo-Botero· Journal of Diabetes Research· 0 citations
Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.
Ke Zhang, Zhi-Fei Chen· Digestive Diseases· 0 citations
OBJECTIVE
To estimate the global burden of type 2 diabetes mellitus (T2DM) attributable to dietary risks among working-age adults from 1990 to 2023, stratified by sex, age, region, and Socio-Demographic Index (SDI). Because Global Burden of Disease (GBD) 2023 data are not disaggregated for ages 15-24, analyses were res...
Xin Chen, Xi-Yue Xiong, L. W. Chan et al.· Diabetes Research and Clinic...· 0 citations
Gastric cancer (GC) remains a major global health issue with high incidence and mortality. This study evaluates the global burden and health disparities of GC from 1990 to 2021 and projects trends through 2036, providing evidence for targeted control measures. The data were sourced from the 2021 Global Burden of Diseas...
Background & Objective: High fasting plasma glucose (HFPG) is a major modifiable metabolic risk factor for cardiovascular disease, chronic kidney disease, premature mortality, and disability. South Asia faces a growing cardiometabolic burden, yet long-term country-level trends, inequalities, and future HFPG-attributabl...
Muhammad Shoaib Khan, Suleman Khan, Safia Wazir et al.· Journal of Saidu Medical Col...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.